πŸ‡ΊπŸ‡Έ FDA
Patent

US 7309483

Method of treatment using Tie2 ligand2

granted A61KA61K38/00

Quick answer

US patent 7309483 (Method of treatment using Tie2 ligand2) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/00